Form 4: CapsoVision Director Awarded 4,045 RSUs

CapsoVision Director Hui Ying Kuo received an award of 4,045 Restricted Stock Units, aligning her interests with shareholders through future vesting.

Summary

• Hui Ying Kuo, a Director of CapsoVision, Inc. (CV), was granted 4,045 Restricted Stock Units (RSUs) on March 19, 2026.
• Each RSU represents a contingent right to receive one share of CapsoVision's common stock.
• The RSUs are scheduled to vest in two equal tranches: 50% on June 30, 2026, and the remaining 50% on December 31, 2026.
• Vesting is contingent upon Ms. Kuo's continued service on the Board through the respective vesting dates.
• Following this transaction, Ms. Kuo beneficially owns 4,045 derivative securities (RSUs).

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a slightly positive development, as it strengthens the alignment between a director's interests and shareholder value, a common and healthy governance practice.

Positives

• The RSU grant aligns the Director's long-term interests with those of shareholders, incentivizing sustained performance and commitment.
• Equity-based compensation is a common practice to attract and retain qualified board members.

Negatives

• The vesting of these RSUs will result in a minor dilution of existing shareholder equity when the shares are issued.

Risks

• The RSUs are subject to forfeiture if the Director's service on the Board ceases before the scheduled vesting dates.

Future Outlook

The RSU grant incentivizes Director Hui Ying Kuo's continued service on the Board through at least December 31, 2026, aligning her compensation with future company performance.

Industry Context

StockSavvy.ai notes that equity-based compensation, such as Restricted Stock Units, is a standard practice across industries for non-employee directors. This method is widely adopted to align the interests of board members with long-term shareholder value creation, particularly in technology and growth-oriented sectors like CapsoVision's.

Comparison to Industry Standards

• The grant of 4,045 RSUs to a non-employee director is within the typical range for director compensation in small to mid-cap public companies, comparable to similar grants seen at companies in the medical device or biotech space, which often use equity to conserve cash and incentivize long-term commitment.
• The two-tranche vesting schedule over approximately nine months is also a common structure, designed to retain directors for a specific period while providing a relatively quick return on their service.

Corporate Governance

Related Party Transactions

• The grant of 4,045 Restricted Stock Units to Director Hui Ying Kuo constitutes a related party transaction, which is a standard form of compensation for non-employee directors.

Stakeholder Impact

• Shareholders: Minor potential dilution upon vesting, but increased alignment of director's interests with long-term shareholder value.

Next Steps

• Vesting of 50% of RSUs on June 30, 2026.
• Vesting of the remaining 50% of RSUs on December 31, 2026.

Key Dates

Recommendation

This Form 4 filing reports a routine equity grant to a director, which is a standard corporate governance practice. It does not contain information significant enough to warrant a change in investment recommendation, but rather reinforces the ongoing alignment of director incentives with shareholder interests. Therefore, a 'hold' recommendation is appropriate, maintaining current positions based on broader company fundamentals.

Keywords

CapsoVision, CV, Hui Ying Kuo, Restricted Stock Units, RSU, Director Compensation, Insider Transaction, Equity Grant, Corporate Governance